CIK 0000899460 · Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133607736
- Phone
- 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $256,334
- in 2 filings, $256K under 10b5-1 plans
Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Thomson David EVP Genl Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-02-26 | Thomson David EVP Genl Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +37,525 | 37,525 | ||
| 2026-02-26 | Tross Stuart A Chief People & Workpl Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-02-26 | Tross Stuart A Chief People & Workpl Officer | Grant or award · Employee Stock Option (right to buy) | +28,143 | 28,143 | ||
| 2026-01-08 | Tross Stuart A Chief People & Workpl Officer | Sale 10b5-1 | −47,006 | $6.33 | $298K | 985,007 |
| 2025-12-24 | Castagna Michael Chief Executive Officer | Gift | −44,171 | 2,460,621 | ||
| 2025-12-17 | Castagna Michael Chief Executive Officer | Option exercise 10b5-1 | +65,804 | $4.55 | $299K | 2,570,596 |
| 2025-12-17 | Castagna Michael Chief Executive Officer | Sale 10b5-1 | −65,804 | $6.01 | $395K | 2,504,792 |
| 2025-12-17 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −15,804 | 0 | ||
| 2025-12-17 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −50,000 | 0 | ||
| 2025-12-16 | Castagna Michael Chief Executive Officer | Option exercise 10b5-1 | +21,310 | $4.55 | $97K | 2,526,102 |
| 2025-12-16 | Castagna Michael Chief Executive Officer | Sale 10b5-1 | −21,310 | $6.00 | $128K | 2,504,792 |
| 2025-12-16 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −21,310 | 15,804 | ||
| 2025-12-12 | Castagna Michael Chief Executive Officer | Option exercise 10b5-1 | +20,806 | $4.55 | $95K | 2,525,598 |
| 2025-12-12 | Castagna Michael Chief Executive Officer | Sale 10b5-1 | −20,806 | $6.00 | $125K | 2,504,792 |
| 2025-12-12 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −7,920 | 0 | ||
| 2025-12-12 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −12,886 | 37,114 | ||
| 2025-12-02 | Castagna Michael Chief Executive Officer | Option exercise 10b5-1 | +107,920 | $4.55 | $491K | 2,612,712 |
| 2025-12-02 | Castagna Michael Chief Executive Officer | Sale 10b5-1 | −107,920 | $5.57 | $601K | 2,504,792 |
| 2025-12-02 | Castagna Michael Chief Executive Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −65,840 | 0 |
Page 5 of 11 · 210 trades